The extended recovery ring stage survival assay provides superior prediction of patient clearance half life and increases throughput
S. Z. Davis, P. P. Singh, K. M. Vendrely, D. Shoue, L. A. Checkley, M. McDew-White, K. A. Button-Simons, Z. Cassady, M. A. C. Sievert, G. J. Foster, F. H. Nosten, T. Anderson, M. T. Ferdig
The paper introduces an improved ring-stage survival assay (eRRSA) that better predicts patient clearance half-life and increases throughput for artemisinin resistance testing.
bioRxiv · Nov 18, 2019 · PreprintMicrobiology